Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aethlon Medical

0.4301
-0.0065-1.49%
Volume:169.41K
Turnover:73.35K
Market Cap:6.22M
PE:-0.43
High:0.4594
Open:0.4408
Low:0.4131
Close:0.4366
Loading ...

Aethlon Medical Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
12 mins ago

Buy Rating for Aethlon Medical Driven by Hemopurifier’s Potential in Organ Transplantation and Projected Growth

TIPRANKS
·
Yesterday

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

PR Newswire
·
Yesterday

Aethlon Medical Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
19 Feb

Q3 2025 Aethlon Medical Inc Earnings Call

Thomson Reuters StreetEvents
·
14 Feb

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

PR Newswire
·
13 Feb

AEMD: Patient Enrollments in Oncology Trial Expected to Accelerate With 3rd Participating Site, Protocol Amendments

Zacks Small Cap Research
·
13 Feb

Aethlon Medical Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
13 Feb

Aethlon Medical Q3 EPS $(0.13) Beats $(0.20) Estimate

Benzinga
·
13 Feb

Aethlon Medical reports Q3 EPS (13c), consensus (20c)

TIPRANKS
·
13 Feb

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

PR Newswire
·
13 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
12 Feb

Aethlon Medical Inc expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
11 Feb

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

PR Newswire
·
05 Feb

Aethlon Medical Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
30 Jan

AEMD Treats First Patient in Australian Safety, Feasibility & Dose-Finding Clinical Trial of Hemopurifier

Zacks Small Cap Research
·
30 Jan